Susan Zweizig to Epothilones
This is a "connection" page, showing publications Susan Zweizig has written about Epothilones.
Connection Strength
0.087
-
De Geest K, Blessing JA, Morris RT, Yamada SD, Monk BJ, Zweizig SL, Matei D, Muller CY, Richards WE. Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: a gynecologic oncology group study. J Clin Oncol. 2010 Jan 01; 28(1):149-53.
Score: 0.087